Introduction
Continuous measurement of the systemic blood pressure and heart rate are routinely obtained in critically ill patients. It is a very basic question to what extent the routinely measured cardiorespiratory parameters provide information about the adequacy of oxygen transport and, more importantly, on the quality of tissue oxygenation. Recognition, prevention, and treatment of tissue hypoxia play a key role in intensive care medicine. The aim of cardiovascular monitoring is the early recognition of impending tissue hypoxia. In some situations, tissue hypoxia may exist despite normal values obtained by conventional hemodynamic monitoring such as arterial blood pressure, central venous pressure, heart rate, and urine output.
Measurement of mixed venous oxygen saturation (SvO 2 ) from the pulmonary artery has for some time been advocated as an indirect index of tissue oxygenation. In myocardial infarction, decreased SvO 2 was found to be indicative of current or imminent cardiac failure [1] . In several diseases such as cardiopulmonary disease, septic shock, cardiogenic shock, and in patients after cardiovascular surgery, a low SvO 2 was associated with a poor prognosis [2] [3] [4] . Based on these findings, fiberoptic pulmonary artery (PA) catheters for continuous SvO 2 measurement have been developed. However, PA catheterization is costly and includes inherent risks. Furthermore, its usefulness in various clinical conditions remains under debate due to a lack of convincing data [5] . In comparison, central venous catheterization via the superior vena cava is part of standard care for critically ill patients and is easier and safer to perform. Similar to the SvO 2 , the measurement of the central venous oxygen saturation (ScvO 2 ) has been advocated as a simple method to assess changes in the adequacy of global oxygen supply in various clinical setting [1] . However, it has been questioned whether this parameter exactly mirrors the SvO 2 especially in critically ill patients. Rivers et al. [6] demonstrated in a recent prospective randomized study in patients with severe sepsis and septic shock that, in addition to maintaining central venous pressure above 8-12 mm Hg, mean arterial pressure above 65 mm Hg, and urine output above 0.5 mL/kg/h, the maintenance of a ScvO 2 above 70% resulted in an absolute reduction of mortality by 15%. These findings refueled the interest in the measurement of ScvO 2 in critically ill patients. The purpose of this review is to discuss the differences and the similarities between mixed and central venous oxygen saturation as well as the potential usefulness of measuring ScvO 2 in clinical practice.
Physiologic differences between SvO 2 and ScvO 2
Mixed venous O 2 content (CvO 2 ) is measured in the pulmonary artery and reflects the relation between whole body O 2 need and cardiac output under conditions of a constant CaO 2 (Fig. 1) . SvO 2 is the most important factor to determine CvO 2 since physically dissolved oxygen reflected by PvO 2 can be neglected and hemoglobin should be constant over a certain period of time in most clinical settings. Due to this relation, SvO 2 has been propagated as a parameter describing the adequacy of tissue oxygenation.
SvO 2 measurement always necessitates the insertion of a pulmonary artery catheter, which is a costly and an invasive procedure. Already in 1969, Scheinman et al. [8] investigated whether the central venous oxygen saturation (ScvO 2 ) reflects changes in SvO 2 .
Venous O 2 saturations differ among several organ systems since they extract different amounts of oxygen. It is therefore reasonable that venous oxygen saturation depends on the site of measurement. In healthy humans, the oxygen saturation in the inferior vena cava is higher than in the superior vena cava. Since the pulmonary artery contains a mixture of blood from both the superior as well as the inferior vena cava, SvO 2 is greater than the oxygen saturation in the superior vena cava. Most commonly, central venous catheters are inserted via a jugular vein or subclavian vein. Thus, central venous blood sampling should reflect the venous blood of the upper body only. However, the tip of the catheter may not only be located in the superior vena cava but also at the superior vena caval/atrial junction or inside the right atrium [9] . About 10-30% of central venous catheters are inserted into the right atrium. It might be therefore possible that blood drawn from a central venous catheter also to some degree contains blood from the inferior vena cava. Furthermore, the catheter tip may be moved depending on the position of the patient. When a patient is moved from a supine to upright position, the catheter moves upwards away from the right atrium due to lengthening of mediastinal structures and vice versa.
Difference between SvO 2 and ScvO 2 in the clinical setting
The physiologic difference between ScvO 2 and SvO 2 is not constant and may be affected by several conditions. These conditions include general anesthesia, severe head injury, redistribution of blood flow as it occurs in shock, and microcirculatory shunting or cell death.
During anesthesia, ScvO 2 may exceed SvO 2 by up to 6% [10] . This observation may be explained by the effect of inhalation anesthetics to increase cerebral blood flow and therefore reducing cerebral O 2 extraction. This leads to a higher SO 2 in the superior vena cava. A similar effect can be observed in patients with elevated intracranial pressures where cerebral trauma and barbiturate coma may decrease cerebral metabolism. Patients with elevated intracranial pressures revealed the highest difference between SvO 2 and ScvO 2 [11 • ].
The reversal of the physiologic difference between ScvO 2 and SvO 2 can also be observed in the state of cardiocirculatory shock. During hemodynamic deterioration, mesenteric blood flow decreases followed by an increase of O 2 extraction in these organs [12] . Naturally, this goes along with venous desaturation in the lower body. On the other hand, cerebral blood flow is maintained over some period in shock causing a delayed drop of ScvO 2 in comparison to SvO 2 . This effect can be demonstrated in several types of shock [11 • ].
Theoretically, the physiologic difference between SvO 2 and ScvO 2 may also be altered if the regional O 2 extraction of a certain organ decreases. This may be due to increased shunting in the microcirculation. Progressive cell death would also decrease oxygen extraction in the affected organ.
Parallel tracking of SvO 2 and ScvO 2
Several animal studies have been performed to prove the reliability of ScvO 2 as a substitute for SvO 2 . High correlation coefficients between ScvO 2 and SvO 2 under various conditions have been reported [13] . As in the experimental setting, a good correlation between ScvO 2 and SvO 2 could be found in critically ill patients [1,11 • ]. It was therefore concluded that ScvO 2 yields adequate information about SvO 2 . However, several conditions such as shock or general anesthesia (see above) affect the physiologic difference between SvO 2 and ScvO 2 . It might be therefore argued that the correlation between ScvO 2 and SvO 2 is clinically unacceptable in critically ill patients.
According to the physiologic properties of ScvO 2 , it is reasonable that a precise determination of SvO 2 by the measurement of ScvO 2 is not possible. However, more important than the precise prediction of SvO 2 is the question whether changes in SvO 2 indicating a hemodynamic derangement or a treatment effect are mirrored by changes in the ScvO 2 . In a dog model, various clinical conditions such as hypoxia and hemorrhagic shock were investigated regarding their effects on these parameters [14] . This study confirmed that ScvO 2 differed from SvO 2 but changes in SvO 2 were accompanied by parallel changes in ScvO 2 (Fig. 2) .
This could also be demonstrated in the clinical setting where 32 critically ill surgical patients were monitored for a total of 1097 hours. A good agreement between SvO 2 and ScvO 2 was shown [11 • ]. The authors concluded that the continuous measurement of ScvO 2 might be a reliable and convenient tool to monitor the adequacy of the oxygen supply/demand ratio. Figure 3 shows an example of a septic patient who developed septic shock on day 3. Although the difference between SvO 2 and ScvO 2 increases after onset of septic shock, the curves of both parameters change in parallel.
Clinical application of SvO 2
Importance of SvO 2 monitoring has been originally proposed in cardiology patients [15] ; however, indications for this monitoring technique have been extended to other areas. One small study demonstrated that maintaining a normal SvO 2 is beneficial in patients with multiple injuries [16] . As this was a non-randomized study, this trial is of low-grade evidence only. Large controlled trials failed to demonstrate an outcome improvement when SvO 2 was used as a treatment goal. One of the most important problems was the fact that a considerable amount of patients did not reach the treatment target.
Gattinoni et al. [17] could not find any difference in morbidity and mortality in a large multicenter trial where critically ill patients were resuscitated to an SvO 2 >70%. However, the anticipated goal was only achieved in one third of the patients.
Polonen et al.
[2] undertook a goal-oriented trial in patients after coronary artery bypass grafting. In the treatment group, SvO 2 was maintained >70% and lactate <2 mmol/l while there was standard care provided to the control group. There was a significant reduction of hospital length of stay by one day in the treatment group. Approximately half of the patients did not achieve the target. Although the study by Polonen et al. gave a hint that SvO 2 monitoring might be beneficial for critically ill patients, trials about the PAC failed to show an outcome improvement for this monitoring device [5] . It may well be that the failure to demonstrate the usefulness of SvO 2 monitoring in most studies results from the fact that these studies enrolled patients too late and/or that this monitoring was without clear treatment algorithms and goals.
Clinical application of ScvO 2
Since monitoring of SCVO 2 looked promising in the experimental setting, several clinical studies including one large randomized trial have been performed in patients with different kinds of shock. This included patients with severe sepsis or septic shock, severe trauma, and cardiogenic shock.
Severe sepsis and septic shock
Severe sepsis and septic shock are frequently complicated by the development of the multiple organ dysfunction syndrome (MODS). Tissue hypoxia is believed to be one of the most important mechanisms for the onset of MODS. However, treatment concepts favoring the achievement of a maximum O 2 delivery proved to be of no benefit to these Changes of ScvO 2 and SvO 2 caused by several experimental manipulations in a dog [14] . Course of mixed venous (SvO 2 ) and central venous (ScvO 2 ) oxygen saturations over several days in a septic patient who developed septic shock on day 3. Modified from [7] .
patients [17] . Furthermore, it is very difficult to define goals for cardiovascular resuscitation in these patients. In this context, Rivers et al. demonstrated in patients with severe sepsis or septic shock that an early and aggressive resuscitation guided by the ScvO 2 additionally to central venous pressure and mean arterial pressure reduced the 28-day mortality rates from 46.5% to 30.5% (P = 0.009) [6] . Compared with the conventionally treated group, the ScvO 2 group received more fluids, more frequently dobutamine, and more blood transfusion during the first 6 hours. This resulted in a faster and better improvement of organ functions in the ScvO 2 group.
Severe trauma and hemorrhagic shock
The care of severely traumatized patients is defined by early and aggressive resuscitation followed by early surgical intervention. Patients with shock, who have been hemodynamically stabilized according to vital signs such as heart rate, blood pressure, and central venous pressure, had an insufficient ScvO 2 in 50% of the cases [18] . These patients with a ScvO 2 <65% were in need of further interventions and demonstrated prolonged cardiac dysfunctions and elevated lactate levels. Although there has been no study that investigated the validity of ScvO 2 to guide hemodynamic stabilization in polytraumatized patients, there is good evidence from patients with severe sepsis or septic shock that the ScvO 2 is a good parameter in the resuscitation of hemodynamically unstable patients [6] .
In initially hemodynamically stable patients after trauma, an ScvO 2 below 65% was able to detect those patients who suffered from blood loss and were in need of blood transfusion [19] . However, in a similar study, only lactate concentrations and arterial base deficit but not ScvO 2 was able to distinguish patients with delayed blood loss from patients without bleeding prior to surgery [20] .
Heart failure and cardiac arrest Heart failure is characterized by a limited cardiac output. Therefore, such patients are unable to sufficiently increase cardiac output during a rise of O 2 need. Changes in need of O 2 can therefore only be covered by changes in O 2 extraction. In these patients, SvO 2 is tightly correlated with cardiac output and a drop in SvO 2 is a good and early marker of cardiac deterioration [15] . Correlation between SvO 2 and ScvO 2 was insufficient in patients with heart failure [8] but was reported to be accurate in patients with myocardial infarction [21] . Nevertheless, patients with congestive heart failure, who present high serum lactate levels and a low ScvO 2 , require a more aggressive management in the emergency department than patients with normal ScvO 2 and normal lactate levels [22] . Patients with an ScvO 2 below 60% were in cardiogenic shock.
During cardiac arrest, cardiopulmonary resuscitation (CPR) is applied to the patient with the goal to reestablish the circulation by the use of standardized procedures. In this setting, continuous ScvO 2 measurement can be helpful in the management during CPR. Venous blood is massively desaturated during cardiac arrest due to maximum O 2 extraction resulting in an ScvO 2 <20%. Successful chest compression leads to an immediate increase of ScvO 2 above 40% [23] . In all patients who reached an ScvO2 >72% during CPR, a return of spontaneous circulation was observed [24] . On the other hand, a very high ScvO 2 (>80%) in the presence of a very low O 2 delivery after successful CPR is also an unfavorable predictor of outcome. It has been argued that a very high ScvO 2 is indicative of an impairment of tissue O 2 utilization probably due to a prolonged cardiac arrest [25] .
Conclusion
Measurement of ScvO 2 is simple and does not necessitate additional invasive techniques. There is a good correlation between ScvO 2 and SvO 2 under non-shock conditions. During the state of circulatory shock, however, ScvO 2 does not always exactly mirror SvO 2 . However, changes of both parameters occur in a parallel manner. Furthermore, changes in SvO 2 due to therapeutic interventions are well reflected in changes of ScvO 2 . This holds true especially in patients with severe sepsis/septic shock and patients with cardiac arrest. In critically ill patients, ScvO 2 is higher than SvO 2 . This implies that a pathologic ScvO 2 indicates an even lower SvO 2 . As many other parameters in intensive care medicine, ScvO 2 should not be used as the only measure in the assessment of the cardiocirculatory system but should be combined with standard vital parameters (heart rate, blood pressure, central venous pressure), lactate measurement, and parameters of organ function (urine output, gastric tonometry). Combining several parameters for a goal-oriented therapy should increase the reliability to achieve stable hemodynamic conditions without evidence of tissue hypoxia.
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